title: ST2 in Pulmonary Disease.
abstract: In recent years, numerous studies have focused on the use of soluble ST2 (sST2) as a clinical biomarker for cardiovascular disease. However, much preclinical data points to involvement of the ST2 pathway in inflammation, and specifically in pulmonary inflammation. This report summarizes the current body of clinical data suggesting the potential role of the ST2 pathway in clinical disease, including evidence that sST2 could be a useful biomarker in both allergic and nonallergic pulmonary disease.
authors: Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: ebajwa@mgh.harvard.edu.
authors: Ednan K
authors: EK
authors: Bajwa
authors: Department of Anesthesiology and Critical Care Medicine, University of Paris Diderot, Paris, France.
authors: Alexandre
authors: A
authors: Mebazaa
authors: Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
authors: James L
authors: JL
authors: Januzzi
mesh_terms: D015415:Biomarkers / Q000097:blood; D006801:Humans; D000072179:Interleukin-1 Receptor-Like 1 Protein; D008171:Lung Diseases / Q000097:blood*; D011956:Receptors, Cell Surface / Q000097:blood*
chemical_list: D015415:Biomarkers; C079241:IL1RL1 protein, human; D000072179:Interleukin-1 Receptor-Like 1 Protein; D011956:Receptors, Cell Surface